Tuesday, May 13, 2008
ABOUT RCI
>Greg Fricchione, MD
Gregory Fricchione, M.D. is Associate Chief of Psychiatry at Massachusetts General Hospital. He was director of the Carter Center Mental Health Program from 2000 to 2002. He is an Associate Professor of Psychiatry at Harvard Medical School, where he has headed the medical psychiatry service at Brigham and Women's Hospital. He was also Director of Research at the Mind-Body Medical Institute at Beth Israel-Deaconess Medical Center in Boston. He co-directed the Harvard Medical School course on spirituality and medicine and serves on a Templeton Foundation committee developing research on altruism.
Dr. Fricchione's clinical work helped establish the use of lorazepam as a first-line treatment for the catatonic syndrome. He also has written extensively about the care of psychiatric patients with medical and neurologic illness. His research in neuroimmunology and neuropsychiatry includes work on macrophage-endothelial cell interaction and led to his appointment to the Dana Farber-Harvard Cancer Center.
A graduate of the New York University School of Medicine, Dr. Fricchione completed a residency and chief residency in psychiatry at the New York University-Bellevue Hospital Center and a fellowship in consultation psychiatry and psychosomatic medicine at Massachusetts General Hospital. He is board certified in general psychiatry and has additional qualifications in geriatric psychiatry.